136 related articles for article (PubMed ID: 16356511)
1. Detection of neutralizing anti-therapeutic protein antibodies in serum or plasma samples containing high levels of the therapeutic protein.
Lofgren JA; Wala I; Koren E; Swanson SJ; Jing S
J Immunol Methods; 2006 Jan; 308(1-2):101-8. PubMed ID: 16356511
[TBL] [Abstract][Full Text] [Related]
2. A non-radioactive method for detecting neutralizing antibodies against therapeutic proteins in serum.
Wala I; Swanson SJ; Jing S
J Pharm Biomed Anal; 2007 Nov; 45(4):583-9. PubMed ID: 17923367
[TBL] [Abstract][Full Text] [Related]
3. Detection and characterization of antibodies against recombinant human erythropoietin by RIPA, ELISA and neutralization assay in patients with renal anemia.
Gross J; Moller R; Bischoff S; Canaan-Kühl S; Fromme M; Henke W
J Immunol Methods; 2008 Jul; 336(2):152-8. PubMed ID: 18501920
[TBL] [Abstract][Full Text] [Related]
4. The detection of anti-erythropoietin antibodies in human serum and plasma: part II. Validation of a semi-quantitative 3H-thymidine uptake assay for neutralizing antibodies.
Kelley M; Cooper C; Matticoli A; Greway A
J Immunol Methods; 2005 May; 300(1-2):179-91. PubMed ID: 15927197
[TBL] [Abstract][Full Text] [Related]
5. Improvement of drug tolerance in immunogenicity testing by acid treatment on Biacore.
Sickert D; Kroeger K; Zickler C; Chokote E; Winkler B; Grenet JM; Legay F; Zaar A
J Immunol Methods; 2008 May; 334(1-2):29-36. PubMed ID: 18304570
[TBL] [Abstract][Full Text] [Related]
6. A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies.
Fournier C; Duverlie G; François C; Schnuriger A; Dedeurwaerder S; Brochot E; Capron D; Wychowski C; Thibault V; Castelain S
Virol J; 2007 Mar; 4():35. PubMed ID: 17397531
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
Stubenrauch K; Wessels U; Lenz H
J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
[TBL] [Abstract][Full Text] [Related]
8. Establishment of humanized anti-interleukin-5 receptor alpha chain monoclonal antibodies having a potent neutralizing activity.
Koike M; Nakamura K; Furuya A; Iida A; Anazawa H; Takatsu K; Hanai N
Hum Antibodies; 2009; 18(1-2):17-27. PubMed ID: 19478395
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics.
Gupta S; Indelicato SR; Jethwa V; Kawabata T; Kelley M; Mire-Sluis AR; Richards SM; Rup B; Shores E; Swanson SJ; Wakshull E
J Immunol Methods; 2007 Apr; 321(1-2):1-18. PubMed ID: 17307199
[TBL] [Abstract][Full Text] [Related]
10. A bioactive drug quantitation based approach for the detection of anti-drug neutralizing antibodies in human serum.
Hu J; Gupta S; Swanson SJ; Zhuang Y
J Immunol Methods; 2009 Jun; 345(1-2):70-9. PubMed ID: 19375427
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a cell-based bioassay for the detection of neutralizing antibodies against recombinant human erythropoietin in clinical studies.
Wei X; Swanson SJ; Gupta S
J Immunol Methods; 2004 Oct; 293(1-2):115-26. PubMed ID: 15541282
[TBL] [Abstract][Full Text] [Related]
12. Development and optimization of a cell-based neutralizing antibody assay using a sample pre-treatment step to eliminate serum interference.
McCutcheon KM; Quarmby V; Song A
J Immunol Methods; 2010 Jun; 358(1-2):35-45. PubMed ID: 20361968
[TBL] [Abstract][Full Text] [Related]
13. Prokaryotic versus eukaryotic recombinant Lutheran blood group protein for antibody identification.
Seltsam A; Grüger D; Blasczyk R
Transfusion; 2007 Sep; 47(9):1630-6. PubMed ID: 17725727
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodies.
Putnak JR; de la Barrera R; Burgess T; Pardo J; Dessy F; Gheysen D; Lobet Y; Green S; Endy TP; Thomas SJ; Eckels KH; Innis BL; Sun W
Am J Trop Med Hyg; 2008 Jul; 79(1):115-22. PubMed ID: 18606774
[TBL] [Abstract][Full Text] [Related]
15. Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA.
Smith HW; Butterfield A; Sun D
Regul Toxicol Pharmacol; 2007 Dec; 49(3):230-7. PubMed ID: 17869396
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing and binding antibodies to interferon beta in patients with multiple sclerosis: a comparison of assay results from three italian centres.
Bellomi F; Bramanti P; Trojano M; Scagnolari C; Muto A; Sessa E; La Volpe V; Russo P; Antonelli G
J Immunoassay Immunochem; 2009; 30(1):40-50. PubMed ID: 19117201
[TBL] [Abstract][Full Text] [Related]
17. Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis A virus infection in vitro and in vivo.
Cao J; Meng S; Li C; Ji Y; Meng Q; Zhang Q; Liu F; Li J; Bi S; Li D; Liang M
J Med Virol; 2008 Jul; 80(7):1171-80. PubMed ID: 18461629
[TBL] [Abstract][Full Text] [Related]
18. Technology comparisons for anti-therapeutic antibody and neutralizing antibody assays in the context of an anti-TNF pharmacokinetic study.
Loyet KM; Deng R; Liang WC; Wu Y; Lowman HB; DeForge LE
J Immunol Methods; 2009 Jun; 345(1-2):17-28. PubMed ID: 19345224
[TBL] [Abstract][Full Text] [Related]
19. Highly specific detection of antibodies to tick-borne encephalitis (TBE) virus in humans using a domain III antigen and a sensitive immune complex (IC) ELISA.
Ludolfs D; Reinholz M; Schmitz H
J Clin Virol; 2009 Jun; 45(2):125-8. PubMed ID: 19409841
[TBL] [Abstract][Full Text] [Related]
20. Isolation of human anti-idiotypic antibodies by phage display for clinical immune response assays.
Tornetta M; Fisher D; O'Neil K; Geng D; Schantz A; Brigham-Burke M; Lombardo D; Fink D; Knight D; Sweet R; Tsui P
J Immunol Methods; 2007 Dec; 328(1-2):34-44. PubMed ID: 17888945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
